Method of detecting or method of quantifying oligonucleotides
AssigneeSekisui Medical Co., Ltd.
InventorsAkane Oomori, Koichi Shibusawa
Life of this patent
Estimating the term…
Loading patent…
AssigneeSekisui Medical Co., Ltd.
InventorsAkane Oomori, Koichi Shibusawa
Estimating the term…
The present invention provides a method of detecting and a method of quantifying oligonucleotides with more excellent specificity and quantitativity as compared to conventional signal amplification (PALSAR) measurement methods. In the present invention, the problem is solved by hybridizing a target oligonucleotide to be measured with a complementary nucleic acid probe (3′-complementary sequence of target sequence-5′), or hybridizing the target oligonucleotide to be measured having given bases such as poly(A) added thereto with a complementary nucleic acid probe (3′-complementary sequence of target oligonucleotide+complementary sequence of given bases-5′), decomposing and removing an incomplete hybridization product by using a single-strand-specific nuclease such as Si nuclease, and measuring the nucleic acid probe contained in a remaining complete hybridization product by a PALSAR method.
A method of detecting a target oligonucleotide in a sample, comprising steps of:
A method of detecting a target oligonucleotide in a sample, comprising steps of:
Dependencies are inferred from the claim text.